Ellagic Acid Holds Promise Against Hepatocellular Carcinoma in an Experimental Model: Mechanisms of Action

This research work was initiated to explore the efficacy of ellagic acid in mitigation of hepatocarcinogenesis in rats. Rats were distributed into 4 groups; negative control, hepatocellular carcinoma (HCC), doxorubicin and ellagic acid. Serum alpha-fetoprotein (AFP), glypican-3 (GPC-3), signal trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaazaa, Asmaa M, Lokman, Maha S, Shalby, Aziza B, Ahmed, Hanaa H, El-Toumy, Sayed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980924/
https://www.ncbi.nlm.nih.gov/pubmed/29479987
http://dx.doi.org/10.22034/APJCP.2018.19.2.387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980924/
https://www.ncbi.nlm.nih.gov/pubmed/29479987
http://dx.doi.org/10.22034/APJCP.2018.19.2.387

Ejemplares similares